SEC Comment Letter 0000000000-26-002279 to Twist Bioscience Corp (TWST) (CIK 0001581280)
Twist Bioscience Corp (TWST) (CIK 0001581280)
Date: March 5, 2026 · CIK: 0001581280 · Accession: 0000000000-26-002279
AI Filing Summary & Sentiment
File numbers found in text: 001-38720
Letter
March 5, 2026 Adam Laponis Chief Financial Officer Twist Bioscience Corporation 681 Gateway Blvd South San Francisco, CA 94080 Re:Twist Bioscience Corporation Form 10-K for Fiscal Year Ended September 30, 2025 File No. 001-38720 Dear Adam Laponis: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences
Show Raw Text
March 5, 2026
Adam Laponis
Chief Financial Officer
Twist Bioscience Corporation
681 Gateway Blvd
South San Francisco, CA 94080
Re:Twist Bioscience Corporation
Form 10-K for Fiscal Year Ended September 30, 2025
File No. 001-38720
Dear Adam Laponis:
We have completed our review of your filing. We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Life Sciences